MOLECULAR PARTNERS AG Weighted Average Exercise Price Of Other Equity Instruments Exercisable In Share-based Payment Arrangement2019
MOLECULAR PARTNERS AG (MOLN) had Weighted Average Exercise Price Of Other Equity Instruments Exercisable In Share-based Payment Arrangement2019 of 0.1 CHF/shares as of 2025-06-30, per its 6-K filed 2025-08-25.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019 · last filed 2025-08-25
- 2025-06-30: Weighted Average Exercise Price Of Other Equity Instruments Exercisable In Share-based Payment Arrangement2019 0.10 CHF/shares.
| Period end | Weighted Average Exercise Price Of Other Equity Instruments Exercisable In Share-based Payment Arrangement2019 |
|---|---|
| 2025-06-30 | 0.10 CHF/shares 6-K · filed 2025-08-25 |